Lymphoid to Myeloid Cell Trans-Differentiation Is Determined by C/EBPβ Structure and Post-Translational Modifications

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Stoilova, Bilyana ^a,b   Kowenz Leutz, Elisabeth ^a   Scheller, Marina ^a,b   Leutz, Achim ^a,b,c  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CEBPB PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL FATE; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DENDRITIC CELL; GENE CONTROL; GENETIC VARIABILITY; GRANULOCYTE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROCESSING; STRUCTURE ANALYSIS; AMINO ACID SUBSTITUTION; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; CELL CULTURE; CHEMISTRY; GENETICS; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION;

PROTEA;

AMINO ACID SUBSTITUTION; ANIMALS; B-LYMPHOCYTES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; IMMUNITY, INNATE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 84878752817     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065169     Document Type: Article

References (50)

1. Graf T, (2011) Historical origins of transdifferentiation and reprogramming. Cell stem cell 9: 504-516.
2. Laiosa CV, Stadtfeld M, Graf T, (2006) Determinants of lymphoid-myeloid lineage diversification. Annual review of immunology 24: 705-738.
3. Tsukada J, Yoshida Y, Kominato Y, Auron PE, (2011) The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54: 6-19.
4. Bussmann LH, Schubert A, Vu Manh TP, De Andres L, Desbordes SC, et al. (2009) A robust and highly efficient immune cell reprogramming system. Cell stem cell 5: 554-566.
5. Garber M, Yosef N, Goren A, Raychowdhury R, Thielke A, et al. (2012) A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Molecular cell 47: 810-822.
6. Hirai H, Kamio N, Huang G, Matsusue A, Ogino S, et al. (2013) Cyclic AMP Responsive Element Binding Proteins Are Involved in 'Emergency' Granulopoiesis through the Upregulation of CCAAT/Enhancer Binding Protein beta. PloS one 8: e54862.
7. Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, et al. (2006) C/EBPbeta is required for 'emergency' granulopoiesis. Nature immunology 7: 732-739.
8. Muller C, Kowenz-Leutz E, Grieser-Ade S, Graf T, Leutz A, (1995) NF-M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line. The EMBO journal 14: 6127-6135.
9. Nerlov C, McNagny KM, Doderlein G, Kowenz-Leutz E, Graf T, (1998) Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes & development 12: 2413-2423.
10. Xie H, Ye M, Feng R, Graf T, (2004) Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676.
11. Feng R, Desbordes SC, Xie H, Tillo ES, Pixley F, et al. (2008) PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proceedings of the National Academy of Sciences of the United States of America 105: 6057-6062.
12. Lichtinger M, Ingram R, Hannah R, Muller D, Clarke D, et al. (2012) RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. The EMBO journal 31: 4318-4333.
13. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A, (1993) Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes & development 7: 749-759.
14. Kowenz-Leutz E, Twamley G, Ansieau S, Leutz A, (1994) Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. Genes & development 8: 2781-2791.
15. Leutz A, Pless O, Lappe M, Dittmar G, Kowenz-Leutz E, (2011) Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs. Transcription 2: 3-8.
16. Lee S, Shuman JD, Guszczynski T, Sakchaisri K, Sebastian T, et al. (2010) RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity. Molecular and cellular biology 30: 2621-2635.
17. Nerlov C, (2008) C/EBPs: recipients of extracellular signals through proteome modulation. Current opinion in cell biology 20: 180-185.
18. Zahnow CA, (2009) CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert reviews in molecular medicine 11: e12.
19. Calkhoven CF, Muller C, Leutz A, (2000) Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes & development 14: 1920-1932.
20. Kowenz-Leutz E, Pless O, Dittmar G, Knoblich M, Leutz A, (2010) Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. The EMBO journal 29: 1105-1115.
21. Lee S, Miller M, Shuman JD, Johnson PF, (2010) CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP). The Journal of biological chemistry 285: 21399-21410.
22. Kowenz-Leutz E, Leutz A, (1999) A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Molecular cell 4: 735-743.
23. Uematsu S, Kaisho T, Tanaka T, Matsumoto M, Yamakami M, et al. (2007) The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing. Journal of immunology 179: 5378-5386.
24. Mink S, Haenig B, Klempnauer KH, (1997) Interaction and functional collaboration of p300 and C/EBPbeta. Molecular and cellular biology 17: 6609-6617.
25. Mo X, Kowenz-Leutz E, Xu H, Leutz A, (2004) Ras induces mediator complex exchange on C/EBP beta. Molecular cell 13: 241-250.
26. Nerlov C, Ziff EB, (1995) CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. The EMBO journal 14: 4318-4328.
27. Pless O, Kowenz-Leutz E, Knoblich M, Lausen J, Beyermann M, et al. (2008) G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. The Journal of biological chemistry 283: 26357-26363.
28. Steinberg XP, Hepp MI, Fernandez Garcia Y, Suganuma T, Swanson SK, et al. (2012) Human CCAAT/enhancer-binding protein beta interacts with chromatin remodeling complexes of the imitation switch subfamily. Biochemistry 51: 952-962.
29. Williams SC, Baer M, Dillner AJ, Johnson PF, (1995) CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. The EMBO journal 14: 3170-3183.
30. Eaton EM, Sealy L, (2003) Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. The Journal of biological chemistry 278: 33416-33421.
31. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, et al. (2009) Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114: 3244-3254.
32. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, et al. (2010) The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature immunology 11: 936-944.
33. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, et al. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. Journal of immunology 172: 4410-4417.
34. Krysinska H, Hoogenkamp M, Ingram R, Wilson N, Tagoh H, et al. (2007) A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene. Molecular and cellular biology 27: 878-887.
35. Rose S, Misharin A, Perlman H, (2012) A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry Part A: the journal of the International Society for Analytical Cytology 81: 343-350.
36. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
37. Vradii D, Wagner S, Doan DN, Nickerson JA, Montecino M, et al. (2006) Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes. Journal of cellular physiology 206: 112-118.
38. Wada T, Kikuchi J, Nishimura N, Shimizu R, Kitamura T, et al. (2009) Expression levels of histone deacetylases determine the cell fate of hematopoietic progenitors. The Journal of biological chemistry 284: 30673-30683.
39. Cumano A, Paige CJ, Iscove NN, Brady G, (1992) Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 356: 612-615.
40. Katoh S, Tominaga A, Migita M, Kudo A, Takatsu K, (1990) Conversion of normal Ly-1-positive B-lineage cells into Ly-1-positive macrophages in long-term bone marrow cultures. Dev Immunol 1: 113-125.
41. Kawamoto H, Katsura Y, (2009) A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid-lymphoid dichotomy. Trends Immunol 30: 193-200.
42. Takahashi K, Miyakawa K, Wynn AA, Nakayama K, Myint YY, et al. (1998) Effects of granulocyte/macrophage colony-stimulating factor on the development and differentiation of CD5-positive macrophages and their potential derivation from a CD5-positive B-cell lineage in mice. Am J Pathol 152: 445-456.
43. Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, et al. (2008) Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 111: 5433-5439.
44. Muroi K, Imagawa S, Suzuki T, Amemiya Y, Miura Y, (1995) B-cell lymphoma terminating in acute monoblastic leukemia. Internal medicine 34: 36-38.
45. Anastasov N, Bonzheim I, Rudelius M, Klier M, Dau T, et al. (2010) C/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica 95: 760-767.
46. Jundt F, Raetzel N, Muller C, Calkhoven CF, Kley K, et al. (2005) A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. Blood 106: 1801-1807.
47. Piva R, Pellegrino E, Mattioli M, Agnelli L, Lombardi L, et al. (2006) Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest 116: 3171-3182.
48. Sterneck E, Tessarollo L, Johnson PF, (1997) An essential role for C/EBPbeta in female reproduction. Genes & development 11: 2153-2162.
49. Collins LS, Dorshkind K, (1987) A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. Journal of immunology 138: 1082-1087.
50. Fortina P, Surrey S, (2008) Digital mRNA profiling. Nature biotechnology 26: 293-294.